This protocol is judged by an institutional evaluation board, an independent team that reviews any medical trials involving humans. If a study entails a Timetable I drug, after the board approves the protocol as moral, the scientists have to submit an application for an investigational new drug (IND) quantity in the FDA.Prospects noted very little